Aortic stenosis

European Heart Journal

Volumn 24, Issue 2, 2003, Pages 133-135

  Zarco, P ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AORTA STENOSIS; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; CALCIFICATION; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SURGICAL TECHNIQUE; TREATMENT PLANNING;

AGED; AGING; AORTIC VALVE STENOSIS; CALCINOSIS; HUMANS; PROSPECTIVE STUDIES;

EID: 0037255062     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(02)00609-7     Document Type: Editorial

References (16)

1. Mönckeberg JG. Der normale histolog ische Bau und die Sklerose der Aortenklappen. Virchows Arch Pathol Anat Physiol 1904;176:472-514.
2. Hudson REB. The aortic valve. Valvar, subvalvar and supravalvar lesions. Cardiovascular Pathology. London: Edward Arnold Ltd; 1965, p. 1037.
3. Edwards JE. On the aetiology of calcific aortic stenosis. Circulation 1962;26:17-8.
4. Mohler ER. Are atherosclerotic processes involved in aorticvalve calcification? Lancet 2000;356:524-5.
5. Lindroos M, Kupari M, Valvanne J et al. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J 1994;15:865-70.
6. Stewart BF, Siscovick D, Lind BK et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 1997;29:630-4.
7. Otto CM, Lind BK, Kitzman DW et al. Association of aorticvalve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:1242-7.
8. Juvonen J, Juvonen T, Laurilia A et al. Can degenerative aortic valve stenosis be related to persistent Clamydia pneumoniae infection? Ann Intern Med 1998;128:741-4.
9. Mohler ER, Gannon F, Reynolds C et al. Bone formation and inflammation in cardiac valves. Circulation 2001; 103:1522-8.
10. Rajamannan NM, Subramaniam M, Springett M et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002;105:2660-5.
11. Glader CA, Birgander LS, Söderberg S et al. Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk marker for valvular aortic stenosis. Eur Heart J 2003;24:198-208.
12. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000; 289:1501-4.
13. Saikku P, Leinonem M, Mattila K et al. Serolgical evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
14. Caliguri G, Rottenberg M, Nicoletti A et al. Clamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 2001;103:2834-8.
15. Sander D, Winbeck K, Klingelhöfer J et al. Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumoniae (Taiwan Acute Respiratory) seropositivity. Circulation 2001;103:1390-5.
16. Novaro GM, Tiong IY, Pearce GL et al. Effect of hydroxymethylglutaryl coenzima A reductase inhibitors on the progression of calific aortic stenosis.